These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Two new fluoroquinolones. Med Lett Drugs Ther; 1992 Jun; 34(872):58-60. PubMed ID: 1317502 [No Abstract] [Full Text] [Related]
4. Pharmacodynamics not likely to appear in antimicrobial labeling soon. Thompson CA Am J Health Syst Pharm; 2006 Nov; 63(22):2168-72. PubMed ID: 17090729 [No Abstract] [Full Text] [Related]
5. The search for new anti-infective drugs: untapped resources and strategies. Bierbaum G; Sahl HG Int J Med Microbiol; 2014 Jan; 304(1):1-2. PubMed ID: 24183099 [No Abstract] [Full Text] [Related]
6. Editorial: Celebrating 40 years of the Journal. Donnelly JP J Antimicrob Chemother; 2016 Jan; 71(1):1-2. PubMed ID: 26677216 [No Abstract] [Full Text] [Related]
8. Antimicrobial agents: the new theriac? Labro MT Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1363-5. PubMed ID: 23253312 [No Abstract] [Full Text] [Related]
9. New developments in antiinfectives research for tropical infectious diseases. Chibale K Bioorg Med Chem; 2015 Aug; 23(16):5085-6. PubMed ID: 26014483 [No Abstract] [Full Text] [Related]
10. Summaries for patients. Linezolid. Ann Intern Med; 2003 Jan; 138(2):I44. PubMed ID: 12529109 [No Abstract] [Full Text] [Related]
12. Could repurposing existing drugs be an efficient protective method against microbial biologic threats? Chopra S Future Microbiol; 2013 Aug; 8(8):951-2. PubMed ID: 23902140 [No Abstract] [Full Text] [Related]
13. Challenges in pharmacodynamic studies of antimicrobial resistance. Rapp RP; Campion JJ Ann Pharmacother; 2003 Sep; 37(9):1329-30. PubMed ID: 12921518 [No Abstract] [Full Text] [Related]
14. Discovery and Development of New Anti-infectives: Perspectives and Prospective. Kothari V Curr Drug Discov Technol; 2020; 17(4):414. PubMed ID: 32907529 [No Abstract] [Full Text] [Related]
15. Fluoroquinolone AUIC break points and the link to bacterial killing rates: in vitro models. Zhanel GG; Noreddin AM Ann Pharmacother; 2003 Sep; 37(9):1331-4. PubMed ID: 12921519 [No Abstract] [Full Text] [Related]
16. Future potential for anti-infectives from bacteria - how to exploit biodiversity and genomic potential. Müller R; Wink J Int J Med Microbiol; 2014 Jan; 304(1):3-13. PubMed ID: 24119567 [TBL] [Abstract][Full Text] [Related]
17. Cefdinir--a new oral cephalosporin. Med Lett Drugs Ther; 1998 Aug; 40(1034):85-7. PubMed ID: 9731242 [No Abstract] [Full Text] [Related]
18. [Successful concept: proteases as targets for anti-infectives. New targets in the treatment of infection]. Schirmeister T; Welker A Pharm Unserer Zeit; 2009; 38(6):564-74; quiz 576-7. PubMed ID: 19862729 [No Abstract] [Full Text] [Related]
19. Editorial overview: Recent advances in antimicrobial drug discovery and resistance. Rogers PD; Lee RE Curr Opin Microbiol; 2023 Feb; 71():102242. PubMed ID: 36423503 [No Abstract] [Full Text] [Related]